(R)-(4,4-bis(3-methyl-2-thienyl)-3-butenyl)-3-piperidinecarboxylic acid, hydrochloride,
Gabitril,
N-(4,4-di(3-methylthien-2-yl)but-3-enyl)nipecotic acid,
NO 328,
NO 329,
NO-328,
NO-329,
tiagabine,
Tiagabine Hydrochloride,
tiagabine, (S)-isomer,
tiagabine,
115103-54-3,
Gabitril,
Tiagabinum,
Tiagabina,
(R)-Tiagabine,
Tiagabinum [INN-Latin],
Tiagabina [INN-Spanish],
Tiagabine [INN:BAN],
Tiagabine [INN],
Abbott-70569,
UNII-Z80I64HMNP,
Tiagabine (INN),
ABBOTT-70569-1,
Gabitril (TN),
CHEMBL1027,
Z80I64HMNP,
ABT-569,
CHEBI:9586,
NO-328,
(-)-(R)-1-(4,4-Bis(3-methyl-2-thienyl)-3-butenyl)nipecotic acid,
NO328,
A-70569-1,
(R)-1-(4,4-Bis(3-methylthiophen-2-yl)but-3-en-1-yl)piperidine-3-carboxylic acid,
Gabatril,
NO050328,
NO 329,
(3R)-1-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]piperidine-3-carboxylic acid,
NO-329,
(-)-(r)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid,
[3H]tiagabine,
(-)-(R)-1-[4,4-Bis(3-methyl-2-thienyl)-3butenyl]nipecotic acid hydrochloride,
(3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-en-1-yl]piperidine-3-carboxylic acid,
3-Piperidinecarboxylic acid, 1-(4,4-bis(3-methyl-2-thienyl)-3-butenyl)-, (R)-,
TGB,
NCGC00164626-01,
NO 328,
C20H25NO2S2,
HSDB 7527,
(3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-enyl]piperidine-3-carboxylic acid,
(R)-1-(4,4-bis(3-methylthiophen-2-yl)but-3-enyl)piperidine-3-carboxylic acid hydrochloride,
NO 050328,
AC1L1TNE,
SCHEMBL34653,
BIDD:GT0018,
AC1Q5R43,
GTPL4685,
GTPL4818,
DTXSID5023663,
PBJUNZJWGZTSKL-MRXNPFEDSA-N,
HY-B0696,
ZINC3831531,
BDBM50039251,
BDBM50368628,
s4675,
NO050328;NO328;TGB,
AKOS016011165,
AC-7048,
AN-9377,
API0009125,
CS-2936,
DB00906,
AJ-45795,
CC-35052,
AX8154081,
LS-114651,
FT-0631075,
C07503,
D08588,
EN300-222195,
103T543,
C-21249,
BRD-K60160658-003-08-8,
(R)-(-)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid,
(r)-n-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]nipecotic acid,
(3R)-1-[4,4-bis(3-methyl-2-thienyl)but-3-enyl]piperidine-3-carboxylic acid,
(R)-1-(4,4-bis(3-methylthiophen-2-yl)but-3-enyl)piperidine-3-carboxylic acid,
(R)-1-[4,4-Bis-(3-methyl-thiophen-2-yl)-but-3-enyl]-piperidine-3-carboxylic acid,
(S)-1-(4,4-bis(3-methylthiophen-2-yl)but-3-enyl)piperidine-3-carboxylic acid,
1-[4,4-Bis-(3-methyl-4,5-dihydro-thiophen-2-yl)-but-3-enyl]-piperidine-3-carboxylic acid,
3-Piperidinecarboxylic acid, 1-[4,4-bis(3-methyl-2-thienyl)-3-buten-1-yl]-, (3R)-,
(R)-1-[4,4-Bis-(3-methyl-thiophen-2-yl)-but-3-enyl]-piperidine-3-carboxylic acid; hydrochloride,
1-[4,4-Bis-(3-methyl-thiophen-2-yl)-but-3-enyl]-piperidine-3-carboxylic acid; hydrochloride,
Tiagabine hydrochloride,
TIAGABINE HCl,
tiagabine, (S)-isomer,
Abbott-70569.1,
D0C1XB,
D0ED7U,
CID60648,
NNC-05-0328,
C20-H25-N-O2-S2,
CS-O-02469,
NO-05-0328,
2070B,
N-(4,4-di(3-methylthien-2-yl)but-3-enyl)nipecotic acid,
C059205,
D000078308,
(3R)-1-[4,4-Bis(3-methyl-2-thienyl)-3-buten-1-yl]-3-piperidinecarboxylic acid,
(R)-(4,4-bis(3-methyl-2-thienyl)-3-butenyl)-3-piperidinecarboxylic acid, hydrochloride,
3-Piperidinecarboxylic acid, 1-(4,4-bis(3-methyl-2-thienyl)-3-buten-1-yl)-, (3R)-,
109857-64-9,